Enzymatic Therapy

Artery Advantage Circulatory Support

Serving

1 Enteric Coated Tablet(s)

Form

tablet

UPC

763948028832

DSLD

24636

Formula hash

094a788395dd

Brand context

Enzymatic Therapy

Catalog

675

products

With avoid flag

118

products

FDA recalls

history

CAERS

reports

Avoid-flaggedObjective label signals

Flagged excipients

1 avoid · 0 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

6 active ingredients

Ingredient	Amount	% DV
Vitamin B6 vitaminUNII · KV2JZ1BI6Z UL · set6 effects	20 mg	1000%
Folate vitaminUNII · 935E97BOY8 UL · set2 effects	800 mcg	200%
Vitamin B12 vitaminUNII · 8406EY2OQA 3 effects	400 mcg	6667%
Garlinase 5000 Garlic Blend Garlicherb	320 mg	—
Pomegranate Fruit Extract PomegranateherbUNII · 56687D1Z4D	50 mg	—
Vitamin K2 Vitamin K (menaquinone)vitaminUNII · 71ANL51TLA	45 mcg	—

What this product supports · authorized claims

6 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

↑Normal energy-yielding metabolism
from: Vitamin B12 · Vitamin B6
EFSAEU-Reg-432/2012-ID-75 →
↑Normal nervous system function
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-66 →
↑Normal immune system function
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-73 →
↑Normal formation of red blood cells + hemoglobin
from: Folate · Vitamin B12 · Vitamin B6
EFSAEU-Reg-432/2012-ID-67 →LOINC 789-8
↓Normal homocysteine metabolism
from: Folate · Vitamin B12 · Vitamin B6
EFSAEU-Reg-432/2012-ID-77 →LOINC 13965-9
↓Reduction of tiredness and fatigue
from: Vitamin B6
EFSAEU-Reg-432/2012-ID-78 →

Flagged excipients

1 flagged · authority citations

● AVOIDTitanium Dioxide color
color
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →

FDA CAERS · adverse event context

consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Cellulose · Rice Dextrin · modified Cellulose Gum · Modified Cellulose · Silicon Dioxide · Magnesium Stearate · Sodium Alginate · Ammonium Hydroxide · fractionated Coconut Oil · Oleic Acid · Stearic Acid

Chemically equivalent

Same formula, different brand

Products with identical sorted (ingredient, amount) tuples.

Enzymatic Therapy
Artery Advantage
→